Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis

BACKGROUND: In the current context of personalized medicine, one of the major challenges in the management of rheumatoid arthritis (RA) is to identify biomarkers that predict drug responsiveness. From the European APPRAISE trial, our main objective was to identify a gene expression profile associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Derambure, C., Dzangue-Tchoupou, G., Berard, C., Vergne, N., Hiron, M., D’Agostino, M. A., Musette, P., Vittecoq, O., Lequerré, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445375/
https://www.ncbi.nlm.nih.gov/pubmed/28545499
http://dx.doi.org/10.1186/s13075-017-1319-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445375/
https://www.ncbi.nlm.nih.gov/pubmed/28545499
http://dx.doi.org/10.1186/s13075-017-1319-8

Ejemplares similares